BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7177307)

  • 1. The Monosodium L-glutamate (MSG) syndrome in mice develops independently of housing condition.
    Barnhart JE; Pizzi WJ
    Neurobehav Toxicol Teratol; 1982; 4(5):549-56. PubMed ID: 7177307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse.
    Lorden JF; Caudle A
    Neurobehav Toxicol Teratol; 1986; 8(5):509-19. PubMed ID: 3785512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal exposure to monosodium glutamate alters the neurobehavioral performance of adult rats.
    Squibb RE; Tilson HA; Meyer OA; Lamartiniere CA
    Neurotoxicology; 1981 Nov; 2(3):471-84. PubMed ID: 7199686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive dysfunction in male rats following neonatal administration of monosodium L-glutamate.
    Pizzi WJ; Barnhart JE; Unnerstall JR
    Neurobehav Toxicol; 1979; 1(1):1-4. PubMed ID: 551297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A behavioral assessment of arcuate nucleus damage after a single injection of monosodium glutamate.
    Dawson R; Annau Z
    Neurobehav Toxicol Teratol; 1983; 5(4):399-406. PubMed ID: 6646313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enriched housing masks deficits in place navigation induced by neonatal monosodium glutamate.
    Saari MJ; Fong S; Shivji A; Armstrong JN
    Neurotoxicol Teratol; 1990; 12(1):29-32. PubMed ID: 2314358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects on behaviour after postnatal treatment with monosodium-L-glutamate.
    Klingberg H; Brankack J; Klingberg F
    Biomed Biochim Acta; 1987; 46(10):705-11. PubMed ID: 3446198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain.
    Yu L; Zhang Y; Ma R; Bao L; Fang J; Yu T
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):170-7. PubMed ID: 16257184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral deficits in adult rats treated neonatally with glutamate.
    Hlinák Z; Gandalovicová D; Krejcí I
    Neurotoxicol Teratol; 2005; 27(3):465-73. PubMed ID: 15939206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monosodium glutamate-induced changes of aggression and open-field activity in rats.
    Carter LT; Levesque L
    Neurobehav Toxicol; 1979; 1(4):247-51. PubMed ID: 575996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice.
    Sasaki Y; Suzuki W; Shimada T; Iizuka S; Nakamura S; Nagata M; Fujimoto M; Tsuneyama K; Hokao R; Miyamoto K; Aburada M
    Life Sci; 2009 Sep; 85(13-14):490-8. PubMed ID: 19683013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neonatal treatment with MSG (monosodium glutamate) on hypothalamo-pituitary-thyroid axis in adult male rats.
    Miśkowiak B; Partyka M
    Histol Histopathol; 1993 Oct; 8(4):731-4. PubMed ID: 8305823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and biochemical effects of monosodium glutamate and aspartame, administered individually and in combination in male albino mice.
    Abu-Taweel GM; A ZM; Ajarem JS; Ahmad M
    Neurotoxicol Teratol; 2014; 42():60-7. PubMed ID: 24556450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse.
    Nakajima H; Tochino Y; Fujino-Kurihara H; Yamada K; Gomi M; Tajima K; Kanaya T; Miyazaki A; Miyagawa J; Hanafusa T
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):251-7. PubMed ID: 3909273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice.
    Nakayama D; Magami Y; Azuma T; Inokuchi H; Furukawa M; Ohyashiki J; Yoshimoto T; Mizuguchi J; Moriyasu F; Kawai K; Hattori T
    Obes Res; 2003 Jan; 11(1):87-94. PubMed ID: 12529490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of polyherbal, antiobesity preparation, OB-200G in male and female mice and monosodium glutamate-treated rats.
    Kaur G; Kulkarni SK
    Indian J Exp Biol; 2001 Jun; 39(6):551-7. PubMed ID: 12562018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal influence of monosodium glutamate on the somatometric parameters of rats.
    Cirić M; Najman S; Bojanić V; Cekić S; Nesić M; Puskas N
    Gen Physiol Biophys; 2009; 28 Spec No():155-61. PubMed ID: 19893094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and neurochemical effects of neonatal administration of monosodium L-glutamate in mice.
    Dawson R; Lorden JF
    J Comp Physiol Psychol; 1981 Feb; 95(1):71-84. PubMed ID: 7217414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swim training applied at early age is critical to adrenal medulla catecholamine content and to attenuate monosodium L-glutamate-obesity onset in mice.
    Scomparin DX; Grassiolli S; Marçal AC; Gravena C; Andreazzi AE; Mathias PC
    Life Sci; 2006 Oct; 79(22):2151-6. PubMed ID: 16934841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-induced suppression of food intake is potentiated by neonatal administration of monosodium glutamate to mice.
    Dawson R
    Neurobehav Toxicol Teratol; 1983; 5(5):523-6. PubMed ID: 6664410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.